Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Fuchs Siegrid |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Hechenberger, S; Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Pichler, A; Fruhwirth, V; Ropele, S; Schmidt, R; Fuchs, S; Enzinger, C Long-term Course and Morphological MRI Correlates of Cognitive Function in Multiple Sclerosis
Annual Meeting of the International Multiple Sclerosis Cognition Society (IMSCOGS); MAI 18-19, 2022; Bordeaux, FRANCE. 2022. [Oral Communication]

 

Damulina, A; Guger, M; Borsodi, F; Leitner-Pohn, D; Pichler, A; Fuchs, S; Pirpamer, L; Langkammer, C; Ropele, S; Fazekas, F; Enzinger, C Variability of MRI measures of focal and global tissue damage in MS in clinical practice – insights from two Austrian MS Centers.
NeuoLogisch. 2019; -16. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 20-22, 2019; Eisenstadt, AUSTRIA. [Poster]

 

Klein, GE; Niederkorn, K; Gattringer, T; Fuchs, S; Enzinger, C; Payer, F; Urbanic-Purkart, T Graz Neurology Symposium - Historical development, present status and future aspects of diagnosis and treatment.
MIND & BRAIN - 59th International Neuropsychiatric Congress; May 30 - June 02, 2019; Pula, CROATIA. 2019. [Oral Communication]
FullText

 

Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Fruhwirth, V; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C Long-term course of cognitive function and disability in patients with MS.
8th Annual Meeting of the International MS Cognition Society; JUN 6-7, 2019; Amsterdam, THE NETHERLANDS. 2019. [Poster]

 

Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Fruhwirth, V; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C The evolution of cognitive function in MS over ten years and the association with MRI findings
MULT SCLER J. 2019; 25: 400-401.-35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS; SEP 11-13, 2019; Stockholm, SWEDEN. [Oral Communication]
Web of Science

 

Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Fruhwirth, V; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C Diagnosis and monitoring of MS associated neurocognitive disorder: tests, assessment tools, computer interface etc
MULT SCLER J. 2019; 25(8):NP12-NP12.-Annual Meeting of the International-Multiple-Sclerosis-Cognition-Society (IMSCOGS); JUN 06-07, 2019; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

Stryeck, S; Voortman, M; Enzinger, C; Fuchs, S; Deisenhammer, F; Hegen, H; Fazekas, F; Madl, T; Khalil, M Serum NMR spectroscopy metabolomic profiles indicate progressive multiple sclerosis
EUR J NEUROL. 2019; 26: 241-241. [Poster]
Web of Science

 

Hallwirth, F; Moser, D; Voortman, M; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H; Fazekas, F; Khalil, M Immunomodulatory therapy reduces elevated serum nitric oxide levels in multiple sclerosis patients.
Neurologisch. 2018; 2018(S1):63-63.-15. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 21-23, 2018; Linz, AUSTRIA. [Poster]
FullText

 

Hallwirth, F; Moser, D; Voortman, M; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, HJ; Fazekas, F; Khalil, M Immunomodulatory therapy reduces elevated nitric oxide levels in multiple sclerosis patients
EUR J NEUROL. 2018; 25: 254-254.-4th Congress of the European Academy of Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL. [Poster]
Web of Science

 

Hallwirth, F; Moser, D; Voortman, MM; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H; Fazekas, F; Khalil, M Serum nitric oxide is increased in untreated in multiple sclerosis patients.
Abstract book CSF Society. 2018; 26. – Abstracts of the 2nd Meeting of the Society for CSF analysis and clinical neurochemistry (CSF Society); June 7-8, 2018; Amsterdam, The Netherlands. [Poster and Abstract].. 2018; 26-26.-2nd Meeting of the Society for CSF analysis and clinical neurochemistry; JUN 7-8, 2018; Amsterdam, THE NETHERLANDS. [Poster]
FullText

 

Hallwirth, F; Moser, D; Voortman, M.M; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H-J; Fazekas, F; Khalil M Immunomodulatory therapy reduces elevated NOX levels in multiple sclerosis patients
2nd Meeting of the Society for CSF analysis and clinical neurochemistry ; JUN 7-8, 2018; Amsterdam. 2018. [Poster]
FullText

 

Pichler, A; Hochstrasser, D; Khalil, M; Langkammer, C; Pirpamer, L; Pinter, D; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F The effect of smoking on 'normal appearing white matter' and lesion load in periventricular regions of patients with multiple sclerosis
MULT SCLER J. 2018; 24: 582-582. [Poster]
Web of Science

 

Schoonheim, MM; Pinter, D; Meijer, KA; Eijlers, AJC; Pirpamer, L; Khalil, M; Pichler, A; Fuchs, S; Fazekas, F; Uitdehaag, BMJ; Barkhof, F; Enzinger, C; Geurts, JJG Specific patterns of thalamic functional connectivity changes related to disability and cognitive impairment in multiple sclerosis
MULT SCLER J. 2018; 24: 613-614. [Poster]
Web of Science

 

Voortman, M; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos-Garcia, JJ; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early Multiple Sclerosis (MS)
EUR J NEUROL. 2018; 25: 434-434.-4th Congress of the European-Academy-of-Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL. [Oral Communication]
Web of Science

 

Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger, C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M The effect of disease modifying therapies on CD62L expression in multiple sclerosis.
Multiple Sclerosis Journal, ECTRIMS 2018. 2018; 24(S2):255-255.-34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY. [Poster]
Web of Science FullText

 

Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger; C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M The effect of disease modifying treatment on CD62L expression in multiple sclerosis
Abstract book Doctoral Day Retrain the Brain 2018. 2018; 64-64.-Doctoral Day Retrain the Brain; NOV 28, 2018; Graz, AUSTRIA. [Poster]
FullText

 

Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, J-J; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Abstract book 2nd Meeting of the Society for CSF analysis and clinical neurochemistry. 2018; 73-73.-2nd Meeting of the Society for CSF analysis and clinical neurochemistry; JUN 7-8, 2018; Amsterdam, THE NETHERLANDS. [Poster]
FullText

 

Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Neurologisch. 2018; 2018(S1):61-61.-15. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 21-23, 2018; Linz, AUSTRIA. [Poster]
FullText

 

Hallwirth, F; Moser, D; Voortman, MM; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H-J; Fazekas; Khalil, M Serum nitric oxide is increased in untreated multiple sclerosis patients.
Mult Scler J. 2017; 23(S3):586-587.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science

 

Kober, SE; Pinter, D; Fuchs, S; Neuper, C; Fazekas, F; Enzinger, C; Wood, G Train Your Brain: Neurofeedback for Cognitive Rehabilitation in Multiple Sclerosis
MULT SCLER J. 2017; 23(6):882-882.-22nd Annual RIMS Conference on Shaping the Future of MS Rehabilitation; MAY 04-06, 2017; Barcelona, SPAIN. [Poster]
Web of Science

 

Pinter, D; Beckmann, C; Fazekas, F; Khalil, M; Pichler, A; Ropele, S; Fuchs, S; Enzinger, C Morphologic MRI phenotyping of multiple sclerosis associates with altered brain function
MULT SCLER J. 2017; 23: 539-540. [Poster]
Web of Science

 

Pinter, D; Fazekas, F; Damulina, A; Pirpamer, L; Pichler, A; Khalil, M; Ropele, S; Fuchs, S; Enzinger, C Evolution of cognitive function in MS and its relationship to physical disability and MRI metrics
MULT SCLER J. 2017; 23: 285-286. [Poster]
Web of Science

 

Pinter, D; Pirpamer, L; Damulina, A; Fazekas, F; Pichler, A; Khalil, M; Fuchs, S; Enzinger, C Long-term course of cognitive function and disability in patients with MS
MULT SCLER J. 2017; 23(8): NP1-NP1. [Oral Communication]
Web of Science

 

Voortman, M; Pekar, T; Bachmayer, D; Archelos-Garcia, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M The role of serum netrin-1 in early multiple sclerosis.
EUR J NEUROL. Eur J Neurol 2017; 24 (Suppl 1). 2017; 24: 313-313.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS. [Poster]
Web of Science FullText

 

Voortman, MM; Pekar, T; Bachmayer D; Archelos, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M The role of serum netrin-1 in early multiple sclerosis.
Neurologisch. 2017; 2017(S2):50-51.-14. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); Mar 22-24, 2017; Villach, Austria; MAR 22-24, 2017; Villach, AUSTRIA. [Oral Communication]

 

Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Doctoral day of the Medical University of Graz; DEC 13, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Multiple Sclerosis Journal. 2017; 23(S3):303-304.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science FullText

 

Kober, SE; Pinter, D; Fuchs, S; Neuper, C; Fazekas, F; Enzinger, C; Wood, G Neurofeedback as cognitive training tool in multiple sclerosis - a first exploratory study
MULT SCLER J. 2016; 22: 813-814.
Web of Science

 

Moser, A;Spindelboeck, W;Strohmaier, H; Enzinger, C; Gattringer, T; Fuchs, S; Fazekas, F; Gorkiewicz, G; Wurm, P; Högenauer, C; Khalil, M Mucosal biopsy reveals immunologic changes of the colon in patients with early multiple sclerosis.
32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis. 2016; -ECTRIMS; SEP 14-17; London, UK. [Poster]

 

Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F The impact of cardiovascular comorbidities on the temporal evolution of brain volume and lesion load in early multiple sclerosis.
MULT SCLER J. 2016; 22: 70-70.-32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, ENGLAND. [Oral Communication]
Web of Science

 

Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F The impact of cardiovascular comorbidities on the temporal evolution of brain volume and lesion load in patients with early MS.
32nd congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); Sep 14-17, 2016; London, UK. 2016. [Oral Communication]

 

Pinter, D; Beckmann, C; Koini, M; Pirker, E; Filippini, N; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis.
13. Jahrestagung der österreichischen Gesellschaft für Neurologie; MAR 16-19, 2016; Innsbruck, AUSTRIA. 2016. [Oral Communication]

 

Pinter, D; Beckmann, C; Koini, M; Pirker, E; Filippini, N; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis
European Journal of Neurology. 2016; -2nd conference of the European Academy of Neurology; MAY 28-31, 2016; Copenhagen, DENMARK. [Poster]

 

Pinter, D; Khalil, M; Greiner, P; Moser, D; Koini, M; Pirker, E; Pichler, A; Bachmaier, G; Fuchs, S; Fazekas, F; Enzinger, C The relationship between resting-state connectivity alterations and the extent of focal white matter lesion changes in multiple sclerosis.
The 5th biennial conference on resting-state brain connectivity; SEP 21-23, 2016; Vienna, AUSTRIA. 2016. [Poster]

 

Pinter, D; Khalil, M; Greiner, P; Moser, D; Koini, M; Pirker, E; Pichler, A; Bachmaier, G; Fuchs, S; Fazekas, F; Enzinger, C The relationship between resting-state connectivity alterations and the extent of focal white matter lesion changes in multiple sclerosis.
32st Congress of the European Committee for Treatment and Research in Multiple Sclerosis; SEP 14-17, 2016; London, UK. 2016. [Poster]

 

Pinter, D; Khalil, M; Greiner, P; Moser, D; Koini, M; Pirker, E; Pichler, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F; Enzinger, C The relationship between resting-state connectivity alterations and the extent of focal white matter lesion changes in multiple sclerosis
MULT SCLER J. 2016; 22: 759-759.
Web of Science

 

Pinter, D; Khalil, M; Greiner, P; Moser, D; Pirker, E; Pichler, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F; Enzinger, C Lesion filling more strongly affects estimation of grey than white matter volumes in a large patient sample depending on hyperintense lesion load
MULT SCLER J. 2016; 22: 512-512.
Web of Science

 

Spindelboeck, W; Moser, AM; Strohmaier, H; Enzinger, C; Gattringer, T; Fuchs, S; Fazekas, F; Gorkiewicz, G; Wurm, P; Hogenauer, C; Khalil, M Mucosal biopsy reveals immunologic changes of the colon in patients with early multiple sclerosis
MULT SCLER J. 2016; 22: 179-179.
Web of Science

 

Voortman, M; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M No association of serum Netrin-1 with MRI based evidence of disease activity in early multiple sclerosis.
MULT SCLER J. 2016; 22: 274-274.-32nd Congress of the European Committee for Treatment and Research in Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, UNITED KINGDOM. [Poster]
Web of Science

 

Voortman, MM; Bachmayer, D; Pekar, T; Seifert-Held, T; Archelos, J-J; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M The role of serum Netrin-1 in early multiple sclerosis.
Doctoral day Medical University of Graz; DEC 14, 2016; Graz, AUSTRIA. 2016. [Oral Communication]

 

Voortman, MM; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M No association of serum Netrin-1 with MRI based evidence of disease activity in early multiple sclerosis.
Multiple Sclerosis Journal. 2016; 22(S3):274-274.-32nd congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 14-17, 2016; London, UNITED KINGDOM. [Poster]
FullText

 

Voortman, MM; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M The role of serum Netrin-1 in early multiple sclerosis.
BIG-WIG (Bildgebung, Immunpathogenese, Gesundungsfaktoren – Wien, Innsbruck, Graz – bei Multiple Sklerose’; ‘Neuroimaging, immunopathogenesis and salutogenic factors in MS – a collaborative effort of the universities of Vienna, Innsbruck and Graz’) symposium; NOV 22, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]
FullText

 

Voortman, MM; Stojakovic, T; Pirpamer, L; Jehna, M; Langkammer, C; Scharnagl, H; Reindl, M; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
BIG-WIG (Bildgebung, Immunpathogenese, Gesundungsfaktoren – Wien, Innsbruck, Graz – bei Multiple Sklerose’; ‘Neuroimaging, immunopathogenesis and salutogenic factors in MS – a collaborative effort of the universities of Vienna, Innsbruck and Graz’) symposium; NOV 22, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]
FullText

 

Jehna, M; Pirpamer, L; Khalil, M; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Stulnig, F; Deutschmann, H; Fazekas, F; Enzinger, C Periventricular lesion burden in multiple sclerosis correlates with cortical thinning
MULT SCLER J. 2015; 21: 180-181.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. Doi: 10.1177/135245851560 [Poster]
Web of Science FullText FullText_MUG

 

Jehna, M; Pirpamer, L; Khalil, M; Stulnig, F; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Deutschmann, H; Fazekas, F; Enzinger, C Periventricular lesion burden in multiple sclerosis correlates with cortical thinning
EUR J NEUROL. 2015; 22: 155-155.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science FullText

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos, J-J; Fuchs, S; Seifert-Held, T; Fazekas, F. Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation
http://www.eaneurology.org/berlin2015/. 2015; -1st Congress of the European Academy of Neurology; June 20-23, 2015; Berlin, GERMANY. [Oral Communication]

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos, J-J; Fuchs, S; Seifert-Held, T; Fazekas, F. Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation.
Neurologisch, Supplementum 2/2015. 2015; 2015(2):23-23.-12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27; Graz, AUSTRIA. [Poster]

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Bachmaier, G; Archelos, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F Impact of cerebrospinal fluid lipocalin-2 on brain iron accumulation and clinical progression in multiple sclerosis
MULT SCLER J. 2015; 21: 632-632.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

Stojakovic, T; Voortman, MM; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Hematology Reports. 2015; 7(S1):67-67.-7th International Symposium on Clinical Applications of Free Light Chain and Heavy/Light Chain Analysis; APR 16-17, 2015; Edinburgh, UNITED KINGDOM. [Poster]

 

Voortman, M M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M. Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27; Graz, AUSTRIA. 2015. [Poster]

 

Voortman, M.M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J.J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Eur J Neurol. 2015; 22(S1):398-398.-1st Congress of the European Academy of Neurology (EAN); JUN 20-23, 2015; Berlin, GERMANY. [Poster]

 

Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid immunoglobulin free light chains as diagnostic and prognostic tool in clinically isolated syndrome and multiple sclerosis.
Inflame Symposium on Inflammation & Immunology; SEP 14-15, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

 

Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients
MULT SCLER J. 2015; 21: 630-630.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Neurologisch, Supplementum 2/2015. 2015; 2: 25-25.-12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27, 2015; Graz, AUSTRIA. [Poster]

 

Voortman, MM; Stojakovic, T;Jehna, M;Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients.
Multiple Sclerosis Journal. 2015; 21(S11):630-630.-31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 7-10, 2015; Barcelona, SPAIN. [Poster]
FullText

 

Walleczek, NK; Rauschka, H; Bsteh, G; Birkl, CB; Khalil, M; Fuchs, S; Enzinger, C; Fazekas, F; Eggers, C; Leutmezer, F; Salhofer-Polanyi, S; Baumgartner, A; Blechinger, S; Koppi, S; Sellner, J; Kraus, J; Assar, H; Gugger, M; Ehling, R; Moser, H; Raber, B; Liendl, H; Parigger, S; Mayr, M; Hiller, MS; Meister, B; Morgenstern, G; Spiess, HK; Kempf, I; Cisar, A; Bachler, H; Lehninger, R; Berger, T; Kristoferitsch, W; Aboulenein-Djamshidian, F Month-of-birth-effect in multiple sclerosis in Austria
MULT SCLER J. 2015; 21: 102-103.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

Enzinger, C (presented on behalf of Khalil M); Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F; Dynamics of brain iron accumulation differ between clinically isolated syndrome and multiple sclerosis: a longitudinal 3T MRI study.
EUR J NEUROLOGY. EUROPEAN JOURNAL OF NEUROLOGY21: 58-58. HOBOKEN: WILEY-BLACKWELL; ( Presented at: Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014) [Oral Communication]
Web of Science

 

Jehna, M; Pirpamer, L; Khalil, M; Fazekas, F; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Stulnig, F; Enzinger, C Kortikale Atrophie und periventrikuläre Läsionen bei Multipler Sklerose - idente Pathophysiologie?
14. Österreichisches fMRT Symposium (ÖGfMRT); Dec 13, 2014; Graz, AUSTRIA. 2014. [Oral Communication]

 

Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Gattringer, T; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F Dynamics of brain iron accumulation differ between clinically isolated syndrome and definite multiple sclerosis: a longitudinal 3T MRI study
Proceedings of the 2014 Joint ACTRIMS-ECTRIMS Meeting. 2014; -2014 JOINT ACTRIMS-ECTRIMS MEETING; SEPT 10-13, 2014; BOSTON, MA USA. [Poster]
FullText

 

Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Gattringer, T; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F Dynamics of brain iron accumulation differ between clinically isolated syndrome and definite multiple sclerosis: a longitudinal 3T MRI study
Multiple Sclerosis Journal - 2014 Joint Actrims-Ectrims Meeting (MS Boston 2014). 2014; 20(S1):269-269.-MS Boston 2014 - Joint ACTRIMS-ECTRIMS Meeting; SEP 10-13, 2014; Boston, USA. [Poster]
Web of Science FullText

 

Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F Dynamics of brain iron accumulation differ between clinically isolated syndrome and multiple sclerosis: a longitudinal 3T MRI study
J NEUROL. 2014; 261: S43-S43.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY. [Oral Communication]
Web of Science

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C;Ropele, S; Stojakovic, T; Scharnagl, H; Archelos, J-J; Fuchs, S; Seifert-Held, T; Fazekas, F Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation
NCA NUBIN 2014 Symposium - The 5th biannual symposium on body fluid biomarkers for inflammation and neurodegeneration.; October 29-30, 2014; Amsterdam, THE NETHERLANDS. 2014. [Oral Communication]

 

Pichler, A; Khalil, M; Langkammer, C; Bachmaier, G; Ropele, S; Fuchs, S; Pinter, D; Enzinger, C; Fazekas, F; . Longitudinal changes of global and compartmental brain atrophy in patients with clinically isolated syndrome and clinically definite multiple sclerosis using 3-Tesla Magnetic Resonance Imaging.
Jahrestagung der österreichischen Gesellschaft für Neurologie ; März 26-29, 2104; Salzburg. 2014. [Poster]

 

Pichler, A; Khalil, M; Langkammer, C; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Pinter, D; Enzinger, C; Fazekas, F Longitudinal changes of global and compartmental brain atrophy in patients with clinically isolated syndrome and clinically definite multiple sclerosis using 3-Tesla magnetic resonance imaging
J NEUROL. 2014; 261: S44-S44.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY. [Oral Communication]
Web of Science

 

Pichler, A; Khalil, M; Langkammer, C; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Pinter, D; Enzinger, C; Fazekas, F; Longitudinal changes of global and compartmental brain atrophy in patients with clinically isolated syndrome and clinically definite multiple sclerosis using 3-Tesla magnetic resonance imaging.
EUR J NEUROLOGY. EUROPEAN JOURNAL OF NEUROLOGY21: 59-59. HOBOKEN: WILEY-BLACKWELL; ( Presented at: Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014) [Oral Communication]
Web of Science

 

Pinter, D; Beckmann, C; Loitfelder, M; Filippini, N; Pichler A; Fuchs, S; Fazekas, F; & Enzinger, C The Default Mode Network – the resting-state network most sensitive for cerebral functional changes over short-term in Multiple Sclerosis.
11. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 26-29, 2014; Salzburg, AUSTRIA. 2014. [Poster]

 

Pinter, D; Beckmann, C; Loitfelder, M; Filippini, N; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C Functional changes in default mode network activity - the most sensitive resting state fMRI parameter for short-term longitudinal changes in MS
Proceedings of the 2014 Joint ACTRIMS-ECTRIMS Meeting. 2014; -2014 JOINT ACTRIMS-ECTRIMS MEETING ; SEPT 10-13, 2014; BOSTON, MA USA. [Poster]
FullText

 

Pinter, D; Beckmann, C; Loitfelder, M; Filippini, N; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C The default mode network: the resting-state network most sensitive for cerebral functional changes over short-term in multiple sclerosis
J NEUROL. 2014; 261: S248-S248.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY. [Poster]
Web of Science

 

Pinter, D; Beckmann, C; Loitfelder, M; Filippini, N; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C; The default mode network - the resting-state network most sensitive for cerebral functional changes over short-term in multiple sclerosis.
EUR J NEUROLOGY. EUROPEAN JOURNAL OF NEUROLOGY21: 369-369. HOBOKEN: WILEY-BLACKWELL; ( Presented at: Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014) [Poster]
Web of Science

 

Pinter, D; Khalil, M; Pichler A; Langkammer, C; Fuchs, S; Fazekas, F; & Enzinger, C Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in Multiple Sclerosis.
11. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR, 26-29, 2014; Salzburg, AUSTRIA. 2014. [Poster]

 

Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Archelos, A; Fuchs, S; Fazekas, F Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
Journal of Neurological Sciences. 2013; -XXI World Congress od Neurology; SEP 21-26, 2013; Vienna, AUSTRIA. [Poster]

 

Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Teunissen, C; Archelos, JJ; Fuchs, S; Fazekas, F Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
MULT SCLER J. 2013; 19(11): 545-545. [Poster]
Web of Science

 

Khalil, M; Riedlbauer, B;Langkammer, C;Enzinger, C;Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Archelos, J.J; Fuchs, S; Fazekas, F Cerebrospinal fluid (CSF) transferrin levels are reduced in patients with early multiple sclerosis
Journal of Neurology. 2013; 260, Supplement 1: 39-40.-Twenty-Third Meeting of the European Neurologic Society; JUN 8-11, 2013; Barcelona, SPAIN. [Oral Communication]

 

Kuhle, J; Dobson, R; Bestwick, JP; Topping, J; Dalla Costa, G; Khademi, M; Sombekke, M; Killestein, J; Evdoshenko, E; Lazareva, N; Runia, T; Zbornikova, P; Horakova, D; D'Alfonso, S; Thouvenot, E; Moll, N; Hegen, H; Rauch, S; Khalil, M; Fuchs, S; Lindberg, RLP; Derfuss, T; Llufriu, S; Franciotta, D; Roesler, R; Lauda, F; Rajda, C; Drulovic, J; Menge, T; Kieseier, BC; Avsar, T; Marignier, R; Malmestrom, C; Myhr, KM; Wergeland, S; Annibali, V; Romano, S; Carra, A; Laroni, A; Frederiksen, JL; Larsson, HB; Uccelli, A; Martinez, AD; Salvetti, M; Torkildsen, O; Lycke, J; Confavreux, C; Rejdak, K; Bosca, I; Brassat, D; Scarpini, E; Fenoglio, C; Galimberti, D; Siva, A; Hartung, HP; Dujmovic, I; Vecsei, L; Tumani, H; Bergamaschi, R; Colombo, E; Villoslada, P; Saiz, A; Enzinger, C; Kappos, L; Deisenhammer, F; Alvarez-Cermeno, JC; Villar, L; Pelletier, J; Lehmann, S; Castelnovo, G; Barizzone, N; Leone, M; Havrdova, E; Trojano, M; Iaffaldano, P; Direnzo, V; Comabella, M; Tintore, M; Montalban, X; Hintzen, R; Lapin, S; Teunissen, C; Piehl, F; Olsson, T; Furlan, R; Martinelli, V; Comi, G; Ramagopalan, S; Giovannoni, G Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS
MULT SCLER J. 2013; 19(11): 33-34. [Oral Communication]
Web of Science

 

Langkammer, C; Khalil, M; Enzinger, C; Pinter, D; Fuchs, S; Ropele, S; Fazekas, F R2* as a potential MRI measure for demyelination in MS lesions
Journal of Neurology. 2013; 260, Supplement 1: 49-50.-Twenty-Third Meeting of the European Neurologic Society; JUN 8-11; Barcelona, SPAIN. [Oral Communication]

 

Loitfelder, M; Fazekas, F; Koschutnig, K; Fuchs, S; Petrovic, K; Ropele, S; Pichler, A; Mader, A; Jehna, M; Langkammer, C; Schmidt, R; Neuper, C; Enzinger, C Longitudinal fMRI using a cognitive paradigm in patients with Multiple Sclerosis
Human Brain Mapping (HBM); June 16-20, 2013; Seattle. 2013. [Poster]

 

Loitfelder, M;Pinter, D; Jehna, M; Fazekas, F; Fuchs, F; Schmidt, R; Enzinger, C Cognitive state and resting state: a comparison between conventional and emulated fMRI data in healthy and diseased brains
Human Brain Mapping; Jun 16-20, 2013; Seattle. 2013. [Poster]

 

Pinter, D; Beckmann, C; Loitfelder, M; Filippini, N; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C Resting state activity changes associated with cognition in multiple sclerosis over mid-term follow-up
13. Österreichisches fMRT Symposium; DEC 7, 2013; Innsbruck. 2013. [Oral Communication]

 

Pinter, D; Loitfelder, M; Filippini, N; Fuchs, S; Fazekas, F; Enzinger, C Effects of Natalizumab on cognition and resting state networks in patients with active MS.
Human Brain Mapping Conference.; JUN 16-20, 2013; Seattle, US. . 2013. [Poster]

 

Pinter, D; Sumowski, J; DeLuca, J; Fazekas, F; Pichler, A; Khalil, M; Langkammer, C; Fuchs, S; Enzinger, C Educational attainment moderates the effect of T2 lesion load and thalamic atrophy on cognition in multiple sclerosis
MULT SCLER J. 2013; 19(11): 437-438. [Poster]
Web of Science

 

Pinter, D; Sumowski, J; Pichler, A; Khalil, M; Langkammer, C; Fuchs, S; Deluca, J; Fazekas, F; Enzinger, C Educational attainment moderates the effect of t2 lesion load and atrophy on cognition in multiple sclerosis
Journal of Neurological Sciences. 2013; 333(1-2):-XXI World Congress od Neurology; SEP 21-26, 2013; Vienna, AUSTRIA. [Oral Communication]

 

Enzinger, C; Loitfelder, M; Pichler, A; Koschutnig, K; Petrovic, K; Fuchs S; Ropele, S; Jehna, M; Langkammer, C; Mader, A; Neuper, C; Fazekas, F No evidence for dynamic neuroplastic changes in cognitively stable multiple sclerosis patients over two years of follow-up
International Multiple Sclerosis Journal. 2012; -28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 10-13, 2012; Lyon, FRANCE. [Poster]

 

Gebauer, D; Enzinger, C; Loitfelder, M; Filippini, N; Fazekas, F; Fuchs, S An exploratory study on the effect of Natalizumab on resting state networks in Multiple Sclerosis patients
3rd Biennal Conference on Resting State Brain Connectivity; SEP 5-7, 2012; Magdeburg, GERMANY. 2012. [Poster]

 

Jehna, M; Langkammer, C; Khalil, M; Fuchs, S; Neuper, C; Ropele, S; Reishofer, G; Fazekas, F; Enzinger, C; Ebner, F Emotionswahrnehmung bei Multipler Sklerose – eine (f)MRT-Studie
20. Jahrestagung der Österreichischen Gesellschaft für Neuroradiologie (ÖGNR); NOV 22-24; Graz, AUSTRIA. 2012. [Oral Communication]

 

Jehna, M; Langkammer, C; Khalil, M; Fuchs, S; Reishofer, G; Fazekas, F; Ebner, F; Enzinger C Räumliche Beziehung zwischen Änderungen im regionalen kortikalen Volumen und der Integrität assoziierter Faserverbindungen bei Multipler Sklerose
12. Österreichisches fMRT Symposium (ÖGfMRT); Dec 7-8, 2012; Salzburg, AUSTRIA. 2012. [Oral Communication]

 

Jehna, M; Langkammer, C; Pichler, A; Fuchs, S; Reishofer, G; Ebner, F; Fazekas, F; Enzinger, C The spatial relationship of structural cerebral alterations in Multiple Sclerosis
Neuroimage Special Issue 2012 Proceedings of the OHBM Annual Meeting. 2012; -18th Annual Meeting of the Organization for Human Brain Mapping (OHBM); JUN 10-14, 2012; Beijing, CHINA. [Poster]

 

Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Mader, A; Archelos, JJ; Fuchs, S; Blankenstein, MA; Fazekas, F; Teunissen, CE. CSF neural cell adhesion molecule in relation to 3T MRI-metrics in early multiple sclerosis
10. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 14-17, 2012; Graz, AUSTRIA. 2012. [Poster]

 

Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Mader, A; Wallner-Blazek, M; Bachmaier, G; Archelos, JJ; Fuchs, S; Blankenstein, MA; Fazekas, F; Teunissen, CE CSF neural cell adhesion molecule in relation to 3T MRI-metrics in early multiple sclerosis.
Proceedings. 2012; -28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; OCT 10-13, 2012; Lyon, FRANCE. [Poster]

 

Langkammer, C; Liu, T; Khalil, M; Enzinger, C; Jehna, M; Fuchs, S; Fazekas, F; Wang, Y; Ropele, S Quantitative susceptibility mapping in multiple sclerosis
Proceedings. 2012; -28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 10-13, 2012; Lyon, FRANCE. [Poster]

 

Langkammer, C; Liu, T; Khalil, M; Enzinger, C; Jehna, M; Fuchs, S; Fazekas, F; Wang, Y; Ropele, S Quantitative susceptibility mapping in the basal ganglia of multiple sclerosis patients.
Proceedings of the 29th Annual Meeting ESMRMB. 2012; -29th Annual Meeting ESMRMB; OCT 4-6, 2012; Lisbon, Portugal. [Poster]

 

Mader, A; Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Archelos, JJ; Blankenstein, MA; Fuchs, S;Fazekas, F; Teunissen, CE. CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
10. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 14-17, 2012 ; Graz, AUSTRIA. 2012. [Poster]

 

Pichler, A; Enzinger, C; Fuchs, S; Plecko-Starting, B; Gruber-Sedlmayr, U; Linortner, P; Langkammer, C; Khalil, M; Ropele, S; Fazekas, F. Differences and similarities in the evolution of morphologic brain abnormalities between paediatric and adult-onset multiple sclerosis
10. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 14-17, 2012 ; Graz, AUSTRIA. 2012. [Poster]

 

Pinter, D; Filippini, N; Loitfelder, M; Fazekas, F; Fuchs, S; Enzinger, C Kognition und „resting-state“ fMRI bei MS PatientInnen unter Therapie mit Natalizumab
12. Österreichisches fMRTSymposium ; DEC, 8, 2012; Salzburg, AUSTRIA. 2012. [Poster]

 

Svenningsson, A; Celius, E; Schreiber, K; Fuchs, S; Falk, E; Berko, S; Moller, CM; Penner, IK Natalizumab Reduces Fatigue as Measured by the Fatigue Scale for Motor and Cognitive Functions (FSMC) - First Results from the TYNERGY Trial
NEUROLOGY. 2012; 78: -64th Annual Meeting of the American-Academy-of-Neurology (AAN); APR 21-28, 2012; New Orleans, LA. [Poster]
Web of Science

 

Enzinger, C; Fuchs, S; Pichler,A; Wallner-Blazek, M; Khalil, M; Langkammer, C; Ropele, S; Fazekas, F Predicting the severity of relapsing-remitting MS: The contribution of cross-sectional and short-term follow-up MRI data
NeuroLogisch2011; Supplement(März):-9. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 16-19, 2011 ; Vienna, AUSTRIA. [Oral Communication]

 

Jehna, M; Langkammer, C; Ischebeck, A; Wallner-Blazek, M; Neuper, C; Ropele, S; Fuchs, S; Fazekas, F; Enzinger, C The influence of micro- and macrostructural changes on brain function during an emotion perception task in MS
Multiple Sclerosis Journal (Formerly Multiple Sclerosis). 2011; 17(S10):S169--5th Joint Triennial Congress of ECTRIMS and ACTRIMS ; OCT 19–22, 2011 ; Amsterdam, The NETHERLANDS. [Poster]
FullText

 

Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Fuchs, S; Khalil, M; Fazekas, F; Enzinger, C Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces
11. Neuroscience Wintermeeting; MAR 31 - APR 2, 2011; Kitzbühel, AUSTRIA. 2011. [Oral Communication]

 

Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Fuchs, S; Khalil, M; Fazekas, F; Enzinger, C Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces
J NEUROL. 2011; 258: 154-154. [Poster]
Web of Science

 

Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Ropele, S; Fuchs, S; Khalil, M; Fazekas, F; Enzinger, C Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces
NeuoLogisch2011; -9. Jahrestagung der Oesterreichischen Gesellschaft für Neurologie (ÖGN); MAR 16-19, 2011; Vienna, AUSTRIA. [Oral Communication]

 

Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Mader, A; Vane, M; Trentini, A; Wallner-Blazek, M; Archelos, JJ; Blankenstein, MA; Fuchs, S; Fazekas, F; Teunissen, CE CSF neurofilaments and N-acetylaspartate in relation to MRI-metrics at 3T in clinically isolated syndromes suggestive of multiple sclerosis
Multiple Sclerosis Journal (Formerly Multiple Sclerosis). 2011; 17(S10):S266--5th Joint Triennial Congress of ECTRIMS and ACTRIMS; OCT 19–22, 2011 ; Amsterdam, The NETHERLANDS. [Poster]

 

Langkammer, C; Khalil, M; Wallner-Blazek, M; Enzinger, C; Fuchs S; Fazekas, F; Ropele, S Quantitative assessment of iron accumulation in multiple sclerosis
Proceedings of the ISMRM 19th Scientific Meeting & Exhibition2011; -ISMRM 19th Scientific Meeting & Exhibition; MAY 6-13, 2011; Montreal, Canada. [Oral Communication]

 

Loitfelder, M; Fazekas, F; Aspeck, E; Jehna, M; Ropele, S; Fuchs, S; Wallner-Blazek, M; Pichler, A; Petrovic, K; Vollmann, R; Neuper, C; Schmidt, R; Enzinger, C Evidence for resource allocation of the brain to preserve cognitive function with progression of relapsing-remitting multiple sclerosis-Insights from a longitudinal fMRI study
J NEUROL. 2011; 258: 153-154. [Poster]
Web of Science

 

Loitfelder, M; Fazekas, F; Aspeck, E; Jehna, M; Ropele, S; Fuchs, S; Wallner-Blazek, M; Pichler, A; Petrovic, K; Vollmann, R; Neuper, C; Schmidt, R; Enzinger C Evidence for resource allocation of the brain to preserve cognitive function with progression of relapsing-remitting multiple sclerosis – Insights from a longitudinal fMRI study
JATROS - Neurologie & Psychiatrie 20112011; 2: 6-6.-XI Neuroscience Wintermeeting; MAR 31 - APR 02, 2011; Kitzbühel. [Poster]

 

Loitfelder, M; Fazekas, F; Aspeck, E; Jehna, M; Ropele, S; Fuchs, S; Wallner-Blazek, M; Pichler, A; Petrovic, K; Vollmann, R; Neuper, C; Schmidt, R; Enzinger C Evidence for resource allocation of the brain to preserve cognitive function with progression of relapsing remitting Multiple Sclerosis – insights from a longitudinal fMRI study
Konferenzband NeuroLogisch2011; -9. Jahrestagung der Oesterreichischen Gesellschaft für Neurologie (ÖGN); MAR 16-19, 2011; Vienna, Austria. [Poster]

 

Loitfelder, M; Fazekas, F; Neuper, C; Rocca, M; Valsasina, P; Ropele, S; Jehna, M; Fuchs, S; Schmidt, R; Filippi, M; Enzinger C Activation changes in attention networks in Multiple Sclerosis characterized by resting state functional connectivity MRI
Konferenzband NeuoLogisch2011; -9. Jahrestagung der Oesterreichischen Gesellschaft für Neurologie (ÖGN); MAR 16-19, 2011; Vienna, Austria. [Poster]

 

Pichler, A; Enzinger, C; Gruber-Sedlmayr, U; Plecko-Startinig, B; Fuchs, S; Langkammer, C; Linortner, P; Ropele, S; Fazekas, F Differences and similarities in the evolution of morphologic brain abnormalities between paediatric and adult-onset multiple sclerosis patients
Multiple Sclerosis Journal (Formerly Multiple Sclerosis). 2011; 17(S10):S71--5th Joint Triennial Congress of ECTRIMS and ACTRIMS; OCT 19–22, 2011 ; Amsterdam, The NETHERLANDS. [Poster]

 

Enzinger, C; Fazekas, F; Vecsei, L; Jenkinson, M; Ropele, S; Khalil, M; Petrovic, K; Loitfelder, M; Langkammer, C; Aspeck, E; Wallner-Blazek, M; Fuchs, S; Jehna, M; Kincses, T Neurological deficits, cognitive performance, and white matter lesion location in multiple sclerosis.
Multiple Sclerosis2010; 16 (Suppl.)(10):S115-S115.-26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 13-16, 2010; Göteborg, SCHWEDEN. [Poster]

 

Enzinger, C; Pichler, A; Fuchs, S; Wallner-Blazek, M; Khalil, M; Langkammer, C; Ropele, S; Fazekas, F Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data.
Multiple Sclerosis2010; 16 (Suppl.)(10):S260-S260.-26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 13-16, 2010; Gothenburg, SCHWEDEN. [Poster]

 

Fazekas, C; Khalil, M; Enzinger, C; Fuchs, S; Fazekas, F Attachment style and temperament in people with early stages of multiple sclerosis
J PSYCHOSOM RES. 2010; 68(6): 47 [Poster]
Web of Science

 

Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Ropele, S; Ebner, F; Fuchs, S; Khalil, M; Fazekas, F; Enzinger, C Altered network activation during perception of faces in MS and their relationship to brain tissue changes.
Multiple Sclerosis2010; 16 (Suppl.)(10):S109-S109.-26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) & 15th Annual Conference of Rehabilitation in MS (RIMS); OCT 13-16, 2010; Gothenburg, SWEDEN. [Poster]

 

Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Ropele, S; Ebner, F; Fuchs, S; Khalil, M; Fazekas, F; Enzinger, C Emotionswahrnehmung bei Multipler Sklerose – eine fMRT-Studie
INGE St. Kongress; OCT 7, 2010; Graz, AUSTRIA. 2010. [Poster]

 

Jehna, M; Neuper, M; Loitfelder, M; Fuchs, S; Ischebeck, A; Wallner-Blazek, M; Khalil, M; Ropele, S; Fazekas, F; Enzinger, C FMRI correlates of emotional perception in healthy subjects and patients with Multiple Sclerosis - insights from an ongoing study
8. JAHRESTAGUNG DER ÖSTERREICHISCHEN GESELLSCHAFT FÜR NEUROLOGIE; FEB 24-27, 2010; Linz, AUSTRIA. 2010. [Poster]

 

Jehna, M; Wallner-Blazek, M; Khalil, M; Loitfelder, M; Fuchs, S; Ischebeck, A; Ropele, S; Neuper, C; Fazekas, F; Enzinger, C FMRI correlates of neutral and emotional facial recognition in Multiple Sclerosis
16th Annual Meeting of the Organization for Human Brain Mapping; June 6-10, 2010; Barcelona, Spain. 2010. [Poster]

 

Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F Cognitive impairment in patients with a clinically isolated syndrome – correlation with MRI parameters including magnetization transfer imaging
8. JAHRESTAGUNG DER ÖSTERREICHISCHEN GESELLSCHAFT FÜR NEUROLOGIE; FEB 24-27, 2010; Linz, AUSTRIA. 2010. [Poster]

 

Khalil, M; Langkammer, C; Ropele, S; Petrovic, K; Loitfelder, M; Jehna, M; Tscherner, M; Wallner-Blazek, M; Schmidt, R; Enzinger, C; Fuchs, S; Fazekas, F Increased brain iron levels by R2* relaxometry in relation to cognitive deficits in multiple sclerosis.
Mult Scler2010; 16 (Suppl.)(10):S98-S99.-26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) & 15th Annual Conference of Rehabilitation in MS (RIMS); OCT 13-16, 2010 ; Gothenburg, SWEDEN. [Poster]

 

Langkammer, C; Enzinger, C; Fuchs, S; Fazekas, F; Ropele, S Magnetization transfer weighted double inversion recovery for an improved visualization of neocortical and juxtacortical signal abnormalities.
Proceedings of the ISMRM 18th Scientific Meeting & Exhibition2010; -ISMRM 18th Scientific Meeting & Exhibition; MAY 1-7, 2010; Stockholm, SWEDEN. [Poster]

 

Langkammer, C; Enzinger, C; Fuchs, S; Fazekas, F; Ropele, S Magnetization transfer weighted double inversion recovery sequence for improved visualization of neocortical and juxtacortical signal abnormalities.
neurologisch2010; -8. Jahrestagung der Österreichischen Gesellschaft für Neurologie; FEB 24-27, 2010; Linz, AUSTRIA. [Poster]

 

Langkammer, C; Khalil, M; Ropele, S; Wallner-Blazek, M; Enzinger, C; Fuchs S; Fazekas, F Quantitative assessment of iron accumulation in multiple sclerosis lesions using R2* relaxometry.
Multiple Sclerosis2010; 16 (Suppl.)(10):S266-S266.-26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) & 15th Annual Conference of Rehabilitation in MS (RIMS); OCT 13-16, 2010; Gothenburg, SWEDEN. [Poster]

 

Loitfelder, M; Fazekas, F; Enzinger, C; Fuchs, S Bestehen geschlechtskonkordante und –diskordante Einflüsse von ÄrztInnen und Multiple Sklerose PatientInnen in der Behandlung?
Österreichische Gesellschaft für Neurologie (ÖGN); FEB 24-27, 2010; Linz. 2010. [Poster]

 

Loitfelder, M; Valsasina, P; Rocca, M; Ropele, S; Fuchs, S; Pichler, A; Fazekas, F; Schmidt, R; Filippi, M; Enzinger, C Funktionelle Konnektivität der Aufmerksamkeit bei Multipler Sklerose im "Resting State"
Initiative Gehirnforschung Steiermark (INGE St.) - 5 Jahres Jubiläum; OKT 7, 2010; Graz, AUSTRIA. 2010. [Poster]

 

Schmied, M; Zehetmayer, S; Bajer-Kornek, B; Hotzy, C; Zebenholzer, K; Leutmezer, F; Kristoferitsch, W; Reindl, M; Khalil, M; Fuchs, S; Schmidt, H; Fazekas, F; Berger, T; Vass, K; Zimprich; A Assoziationsanalyse von Kandidatenloci für Multiple Sklerose
8. JAHRESTAGUNG DER ÖSTERREICHISCHEN GESELLSCHAFT FÜR NEUROLOGIE; FEB 24-27, 2010; Linz, AUSTRIA. 2010. [Poster]

 

Wallner-Blazek, M; Khalil, M; Petrovic, K; Hochmeister, S; Seifert-Held, T; Enzinger, C; Storch, M; Schmidt, R; Fazekas, F; Fuchs, S Klassifikation und Prognose der Multiplen Sklerose und verwandter Krankheitsbilder.
MUG-Forschungsfeld Neurowissenschaften; JUN 10, 2010; Graz, AUSTRIA. 2010. [Oral Communication]

 

Baumhackl, U; Berger, T; Deisenhammer, F; Fazekas, F; Fuchs, S; Kristoferitsch, W; Ladurner, G; Soukop, W; Vass, K; Wimmer, G Ergebnisse der Studie ACISS
neurologisch2009; Sonderausgabe: 66-66.-7. Jahrestagung der Österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA. [Poster]

 

Enzinger, C; Loitfelder, M; Petrovic, K; Fuchs, S; Ropele, S; Wallner-Blazek, M; Jehna, M; Aspeck, E; Schmidt, R; Neuper, C; Fazekas, F Functional reorganisation in cognitive networks with disease progression in multiple sclerosis.
MULT SCLER. Multiple Sclerosis2009; 15(9):S222-S222.-25th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS); SEPT 9-12, 2009; Duesseldorf, GERMANY. [Poster]
Web of Science

 

Fazekas, F; Fuchs, S 1x1 der MS - Neue Therapien.
20. Grazer Fortbildungstage der Ärztekammer für Steiermark; OCT 5-10, 2009; Graz, AUSTRIA. 2009. [Oral Communication]
FullText

 

Fuchs, S Die Prognose der Multiplen Sklerose
MS: Entstehung, Prognose und geographische Ausbreitung (Informationsveranstaltung für Betroffene und Angehörige veranstaltet von der MS Gesellschaft Wien); MAR 14, 2009; Vienna, AUSTRIA. 2009. [Oral Communication]

 

Fuchs, S Etablierte und neue Strategien in der MS-Therapie.
7. Jahrestagung der Österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA. 2009. [Oral Communication]

 

Fuchs, S Diskussion und Erfahrungsaustausch.
Der Bundesdelegierten Tag der Multiplen Sklerose Gesellschaft ; MARCH 21, 2009; Linz, AUSTRIA . 2009. [Oral Communication]

 

Fuchs, S MS Therapie heute.
Multiple Sklerose Symposium zum Thema "Blase und Sexualität" 2009; -MS Symposium ; MAY 29,2009; Bad Radkersburg, AUSTRIA . [Oral Communication]

 

Jehna, M; Fuchs, S; Loitfelder, M; Neuper, C; Ischebeck, A; Ebner, F; Ropele, S; Schmidt, R; Fazekas, F; Enzinger, C Erste Untersuchungen zu geschlechtsspezifischen Unterschieden in der Emotionswahrnehmung: Einblicke aus der funktionellen MRT (fMRT)
2. Jahrestagung der österreichischen Gesellschaft für geschlechtsspezifische Medizin; APRIL 24-25, 2009; St. Pölten, AUSTRIA. 2009. [Poster]

 

Jehna, M; Loitfelder, M; Neuper, C; Fuchs, S; Ischebeck, A; Ebner, F; Ropele, S; Schmidt, R; Fazekas, F; Enzinger, C A new combined fMRI paradigm to study the neural correlates of the perception of faces and the recognition of emotional facial expression
neurologisch2009; Sonderausgabe: 21-22.-10. Austrian Neuroscience Winter Meeting; MAR 4-7, 2009; Kitzbühel, AUSTRIA. [Poster]

 

Jehna, M; Loitfelder, M; Neuper, C; Fuchs, S; Ischebeck, A; Ebner, F; Ropele, S; Schmidt, R; Fazekas, F; Enzinger, C A New Combined fMRI Paradigm to Study the Neural Correlates of the Perception of Faces and the Recognition of Emotional Facial Expression.
neurologisch2009; Sonderausgabe: 67-68.-7. Jahrestagung der Österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA. [Poster]

 

Jehna, M; Loitfelder, M; Neuper, C; Fuchs, S; Ropele, S; Langkammer, C; Schmidt, R; Fazekas, F; Enzinger, C A new fMRI paradigm to study the recognition process of emotional facial expression in multiple sclerosis.
MULT SCLER. Multiple Sclerosis2009; 15(9):S222-S222.-25th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 9-12, 2009; Duesseldorf, GERMANY. [Poster]
Web of Science

 

Jehna, M; Neuper, C; Loitfelder, M; Fuchs, S; Ischebeck, A; Ebner, F; Ropele, S; Fazekas, F; Enzinger, C How the brain processes emotions- insights from functional MRI (fMRI)
Human Brain Mapping, HBM; JUL 18 - 23, 2009; San Francisco, California, USA. 2009. [Poster]

 

Katzenschlager, R; Fuchs, S ARGE Frauen in der Neurologie (Vorsitz)
7. Jahrestagung der Österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA. 2009.

 

Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F The Spectrum of Cognitive Impairment and Its Relation to Brain Morphology Including Iron Deposition in Multiple Sclerosis.
NEUROLOGY. 2009; 72(11):A142-A142.-61st Annual Meeting of the American Academy of Neurology (AAN); APR 25-May 2, 2009; Seattle, USA. [Poster]
Web of Science

 

Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F The Spectrum of Cognitive Impairment and its relation to Brain Morphology including Iron Deposition in Multiple Sclerosis
neurologisch2009; Sonderausgabe: 14-15.-7. Jahrestagung der Österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA. [Poster]

 

Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F Cognitive impairment in patients with a clinically isolated syndrome - correlation with MRI parameters including magnetization transfer imaging.
MULT SCLER. 2009; 15(9):S227-S228.-25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 9–12, 2009; Düsseldorf, GERMANY. [Poster]
Web of Science

 

Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F The Spectrum of Cognitive Impairment and its relation to Brain Morphology including Iron Deposition in Multiple Sclerosis
neurologisch2009; Sonderausgabe: 23-23.-10. Austrian Neuroscience Wintermeeting; MAR 4-7, 2009; Kitzbühel, AUSTRIA. [Poster]

 

Khalil, M; Enzinger, C; Langkammer, C; Tscherner, M; Wallner-Blazek, M; Jehna, M; Ropele, S; Fuchs, S; Fazekas, F Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing remitting multiple sclerosis
neurologisch2009; Sonderausgabe: 14-14.-7. Jahrestagung der Österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA. [Poster]

 

Khalil, M; Enzinger, C; Langkammer, C; Tscherner, M; Wallner-Blazek, M; Jehna, M; Ropele, S; Fuchs, S; Fazekas, F Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing remitting multiple sclerosis.
Neurology 72 March 17, 2009 (Suppl 3)2009; Suppl. Volume 72(11):435-435.-American Academy of Neurology 61st Annual Meeting, April 25 to May 2, 2009; APR. 25 to MAY 02, 2009; Seattle, USA. [Oral Communication]

 

Khalil, M; Enzinger, C; Langkammer, C; Tscherner, M; Wallner-Blazek, M; Jehna, M; Ropele, S; Fuchs, S; Fazekas, F Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing remitting multiple sclerosis
neurologisch2009; Sonderausgabe: 22-22.-10. Austrian Neuroscience Wintermeeting; MAR 4-7, 2009; Kitzbühel, AUSTRIA. [Poster]

 

Loitfelder, M; Petrovic, K; Fuchs, S; Neuper, C; Wallner-Blazek, M; Jehna, M; Aspeck, E; Schmidt, R; Fazekas, F; Enzinger, C FMRI Evidence for Functional Reorganisation in Cognitive Networks with Disease Progression in Multiple Sclerosis
Neurologisch 2009; Sonderausgabe: 12-12.-7. Jahrestagung der Österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA. [Poster]

 

Loitfelder, M; Petrovic, K; Fuchs, S; Ropele, S; Wallner-Blazek, M; Jehna, M; Aspeck, E; Schmidt, R; Fazekas, F; Enzinger, C FMRI evidence for functional reorganisation in cognitive networks with disease progression in multiple sclerosis
neurologisch2009; Sonderausgabe: 26-26.-10. Austrian Neuroscience Winter Meeting; MAR 4-7, 2009; Kitzbühel, AUSTRIA. [Poster]

 

Loitfelder, M; Petrovic, K; Fuchs, S; Ropele, S; Wallner-Blazek, M; Jehna, M; Aspeck, E; Schmidt, R; Neuper, C; Fazekas, F; Enzinger, C FMRI evidence for functional reorganisation in cognitive networks with disease progression in Multiple Sclerosis
Human Brain Mapping, HBM; JUL 18-23, 2009; San Francsico, California, U.S.A.. 2009. [Poster]

 

Plaschg, A; Haubenhofer, A; Fazekas, F; Fuchs, S; Homann, CN Neurologische Erkrankungen und deren geschlechtsspezifischer Einfluss auf die Verkehrsteilnahmegewohnheiten im Alter.
2. Jahrestagung der Österreichischen Gesellschaft für geschlechtsspezifische Medizin (ÖGGSM); 24. - 25. April 2009; St. Pölten, Austria. 2009. [Poster]

 

Plaschg, A; Haubenhofer, A; Fazekas, F; Fuchs, S; Homann, CN Neurologische Erkrankungen und deren geschlechtsspezifischer Einfluss
neurologisch2009; Sonderausgabe: 77-77.-7. Jahrestagung der Österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA. [Poster]

 

Enzinger, C; Loitfelder, M; Ropele, S; Neuper, C; Petrovic, K; Aspeck, E; Fuchs, S; Fazekas, F Evidence for cortical reorganisation in cognitive domains in multiple sclerosis: insights from a 'Go/NoGo' Task.
Multiple Sclerosis2008; 14(S1):S103-S103.-World Congress on Treatment and Research in Multiple Sclerosis: ACTRIMS + ECTRIMS + LACTRIMS; SEP 17-20, 2008; Montreal, CANADA. [Poster]
Web of Science

 

Enzinger, C; Loitfelder, M; Ropele, S; Neuper, C; Petrovic, K; Gorani, F; Fuchs , S; Fazekas, F Evidence for cortical reorganisation in cognitive domains in Multiple Sclerosis from functional MRI
Neuroimage 2008 (suppl)2008; -Human Brain Mapping; Jun 15-19; Melbourne, Australia. [Poster]

 

Fazekas, F Scientific Committee (Member)
1st Centrope MS Scientific Meeting: Shift the paradigm in the treatment decision in MS; OCT 11, 2008; Dubrovnik, Croatia. 2008.

 

Fuchs, S Die Verträglichkeit bestimmt die Langzeit-Compliance
6. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); FEB 6-9, 2008; Innsbruck, AUSTRIA. 2008. [Oral Communication]

 

Fuchs, S Multiple Sklerose
16. Wissenschaftliche Sitzung der Wissenschaftlichen Gesellschaft der Ärzte in der Steiermark: Neues zu Diagnostik und Therapie wichtiger neurologischer Erkrankungen; JUN 19, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Fuchs, S Natalizumab
MS Akademie der Österreichischen Gesellschaft für Neurologie; OCT 17-18, 2008; Mondsee, AUSTRIA. 2008. [Oral Communication]

 

Fuchs, S Multiple Sklerose: Krankheitsbild/Diagnose/Therapie
Sitzung des Beirates für Menschen mit Behinderung der Stadt Graz; SEP 29, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Fuchs, S Multiple Sklerose
MINI MED Studium; APR 17, 2008; Graz, AUSTRIA. 2008. [Oral Communication]
FullText

 

Fuchs, S Verlaufskontrollen in der Praxis
MS Akademie der Österreichischen Gesellschaft für Neurologie; OCT 17-18, 2008; Mondsee, AUSTRIA. 2008. [Oral Communication]

 

Fuchs, S Die vielen Gesichter der MS
3. Steirischer MS-Tag "Leben mit der Krankheit"; OCT 3, 2008; Judendorf-Straßengel, AUSTRIA. 2008. [Oral Communication]

 

Fuchs, S Derzeitige Therapiekonzepte (Chair)
3. Steirischer MS-Tag "Leben mit der Krankheit"; OCT 3, 2008; Judendorf-Straßengel, AUSTRIA. 2008.

 

Fuchs, S Sicherheit in Langzeittherapie geht vor schnellem therapeutischem Maximaleffekt (contra)
2-Länder-Symposium; MAR 7-9, 2008; Innsbruck, AUSTRIA. 2008. [Oral Communication]

 

Fuchs, S Update Therapie der MS
Interne Fortbildung der Universitätsklinik für Neurologie; JAN 15, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Fuchs, S Die vielen Gesichter der Multiplen Sklerose
Informationsveranstaltung für Multiple Sklerose-Betroffene und Angehörige ; MAY 16,2008; St.Pölten, AUSTRIA . 2008. [Keynote lecture]

 

Fuchs, S Multiple Sklerose
Workshop Forschungsfeld Neurowissenschaften ; NOV 25, 2008; Graz, AUSTRIA . 2008. [Oral Communication]

 

Fuchs, S; Vass, K Immuntherapie der MS heute - ein dynamisches Konzept (Vorsitz)
6. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); FEB 6-9, 2008; Innsbruck, AUSTRIA. 2008.

 

Jehna, M; Loitfelder, M; Neuper, C; Fuchs, S; Fazekas, F; Ebner, F; Ropele, S; Enzinger, C fMRT Untersuchungen zur Emotionswahrnehmung.
ÖGfMRT Symposium 2008; ; DEZ 6-7, 2008; Vienna, AUSTRIA. 2008. [Oral Communication]

 

Khalil, M; Enzinger, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna. M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F Executive dysfunction represents an underestimated component of cognitive impairment in multiple sclerosis.
Multiple Sclerosis2008; 14(S1):S258-S259.-World Congress on Treatment and Research in Multiple Sclerosis: ACTRIMS + ECTRIMS + LACTRIMS; SEPT 17-20, 2008; Montreal, CANADA. [Poster]
Web of Science

 

Khalil, M; Enzinger, C; Petrovic, K; Loitfelder, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F Spectrum of cognitive impairment including higher executive functions in patients with multiple sclerosis
6. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); FEB 6-9, 2008; Innsbruck, AUSTRIA. 2008. [Poster]

 

Loitfelder, M; Franz Fazekas, Katja Petrovic, Siegrid Fuchs, Stefan Ropele, Mirja Wallner-Blazek, Margit Jehna, Engelbert Aspeck, Franz Ebner, Christa Neuper, Christian Enzinger Neuronale Korrelate kognitiver Funktion/Dysfunktion bei Multipler Sklerose
fMRT Symposium 2008; 07.12.2008; Wien. 2008. [Oral Communication]

 

Loitfelder, M; Ropele S, Neuper C, Petrovic K, Gorani F, Ebner F, Fuchs S, Fazekas F, Enzinger C Kortikale Reorganisation in kognitiven Domänen bei multipler Sklerose.
6. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); FEB 6-9, 2008; Innsbruck, AUSTRIA. 2008. [Poster]

 

Strasser-Fuchs, S Multiple Sklerose und Lebensqualität
6. Copaxone Symposium - Neurogenese und Repair bei MS: vom Experiment zur Klinik; JAN 18-19, 2008; Linz, AUSTRIA. 2008. [Oral Communication]

 

Wallner-Blazek, M; Enzinger C, Petrovic K, Loitfelder M, Tscherner M, Jehna M, Khalil M, Ropele S, Schmidt R, Fuchs S, Fazekas F Spectrum of cognitive impairment including higher executive functions in patients with Multiple Sclerosis
52.wissenschaftliche Jahrestagung der deutschen Gesellschaft für klinische Neurophysiologie und funktionelle Bildgebung; 10.-12.4.2008; Magdeburg,Germany. 2008. [Poster]

 

Baumhackl, U; Berger, T; Deisenhammer, E; Fazekas, F; Kristoferitsch, W; Ladumer, G; Soukop, W; Strasser-Fuchs, S; Vass, K; Wimmer, G The Austrian clinically isolated syndrome study (ACISS): baseline results
MULT SCLER. 2007; 13: S104-S105.-23rd Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 11-14, 2007; Prague, CZECH REPUBLIC. [Oral Communication]
Web of Science

 

Jehna M, Enzinger C, Neuper C, Petrovic K, Strasser-Fuchs S, Wallner M, Fazekas F Emotionswahrnehmung bei Multipler Sklerose
5. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); April ; Salzburg. 2007. [Poster]

 

Loitfelder M, Fuchs S, Ropele S, Fazekas F, Petrovic K, Enzinger C Kortikale Reorganisation in kognitiven Netzwerken bei Multipler Sklerose in Abhängigkeit vom klinischen Phänotyp
7. Österreichisches fMRT Symposium; Dezember ; Graz. 2007. [Oral Communication]

 

Popotnig F, Grabner R, Neuper C, Ropele S, Gorani F, Petrovic K, Ebner F, Strasser-Fuchs S, Fazekas F, Enzinger C fMRT Untersuchungen zur Messung der Gehirnaktivität während der Bearbeitung des Faces-Symbol Tests bei Gesunden und PatientInnen mit idiopathischer inflammatorischer ZNS-Erkrankung
5. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); April ; Salzburg. 2007. [Poster]

 

Strasser-Fuchs, S Klinik, Verlaufsformen und Differentialdiagnose
Fortbildungsabend Neurologie - Thema Multiple Sklerose; MAY 15, 2007; Wernberg, AUSTRIA. 2007. [Oral Communication]

 

Strasser-Fuchs, S MS Langzeittherapie und Adhärenz
Biogen-Fortbildung; FEB 15, 2007; Linz, AUSTRIA. 2007. [Oral Communication]

 

Strasser-Fuchs, S Die Verträglichkeit bestimmt die Langzeitcompliance (Workshop)
Rebif Neue Formulierung Launch-Symposium; SEP 28-29, 2007; Mondsee, AUSTRIA. 2007. [Oral Communication]

 

Strasser-Fuchs, S Tysabri - Wirkmechanismen und Indikationsstellung
MS-Update mit Informationen zu Avonex und Tysabri; JUN 2, 2007; Augartenhotel, Graz, AUSTRIA. 2007. [Oral Communication]

 

Strasser-Fuchs, S Tysabri - Wirkmechanismus und Wirkung (Fallbeispiele)
MS-Update mit Informationen zu ACISS (Avonex) und Tysabri; OCT 5, 2007; Augartenhotel, Graz, AUSTRIA. 2007. [Oral Communication]

 

Tscherner M, Enzinger C, Ropele S, Strasser-Fuchs S, Fazekas F Explorative Untersuchungen zur kernspintomographischen Nachweisbarkeit juxtakortikaler und kortikaler Läsionen bei Multipler Sklerose
5. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); April ; Salzburg. 2007. [Poster]

 

Enzinger C, Strasser-Fuchs S, Fazekas F Termination of interval treatment in multiple sclerosis.
MAGNIMS (Magnetic Resonance in Multiple Sclerosis) meeting; Sept; Barcelona. 2006. [Oral Communication]

 

Kristoferitsch, W; Strasser-Fuchs, S Kontroversen in der MS-Therapie: Klinische Marker als Verlaufprädiktoren
3-Länder-Symposium Multiple Sklerose. Individualisierte Therapieentscheidung - machbar?; MAR 3-5, 2006; Dresden, GERMANY. 2006. [Oral Communication]

 

Strasser-Fuchs, S Immuntherapie der MS
Facharztausbildungsseminar der Österreichischen Gesellschaft für Neurologie (ÖGN); NOV 2-4, 2006; Graz, AUSTRIA. 2006. [Oral Communication]

 

Strasser-Fuchs, S Behandlungsbeginn und Dauer der Immuntherapie
24. MS User-Meeting der Österreichischen Gesellschaft für Neurologie (ÖGN); DEC 1, 2006; Salzburg, AUSTRIA. 2006. [Oral Communication]

 

Wallner, M; Enzinger, C; Ropele, S; Strasser-Fuchs, S; Fazekas, F Non-conventional MRI measures of brain tissue integrity fail to explain the preservation of function in some MS patients with an extensive lesion load but a benign course of the disease
MULT SCLER. 2006; 12: S179-S179.-22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis; SEP 27-30, 2006; Madrid, SPAIN. [Poster]
Web of Science

 

Wallner-Blazek, M; Enzinger, C; Ropele, S; Strasser-Fuchs, S; Fazekas, F Clinically benign MS despite large T2 lesion load.Can non conventional MRI or MRS explain this paradoxon.
ECTRIMS; SEPT 27-30,2006; Madrid. 2006. [Poster]

 

Enzinger, C; Ropele, S; Strasser-Fuchs, S; de Stefano, N; Matthews, P; Kapeller, P; Smith, S; Fazekas, F Progressive brain tissue loss and reduction of N-acetylaspartate despite immunomodulatory therapy in relapsing-remitting multiple sclerosis: results of a longitudinal single-centre study analysing MR spectroscopic, brain volume and focal tissue changes
J NEUROL 2005 252: 91-91.
Web of Science

 

Enzinger C, Ropele S, Strasser-Fuchs S, de Stefano N, Matthews PM, Kapeller P, Smith S, Fazekas F. Kombinierte Verlaufsuntersuchung konventioneller MRT- und MR-spektroskopischer Marker zur Beurteilung der Krankheitspogression unter immunmodulatorischer Therapie bei schubförmiger Multipler Sklerose.
3. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); April 2005 ; Graz, Austria. 2005. [Poster]

 

Kapeller P, Ropele S, Enzinger C, Lahousen T, Strasser-Fuchs S, Schmidt R, Fazekas F. Mikroangiopathische Läsionen versus Demyelinisierungsherde.
3. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); April; Graz. 2005. [Oral Communication]

 

Baumhackl, U; Berger, T; Deisenhammer, F; Fazekas, F; Kristoferitsch, W; Ladurner, G; Soukop, W; Strasser-Fuchs, S; Vass, K Austrian clinically isolated syndrome study (ACISS): methodology and first baseline data
MULT SCLER 2004 10: S176-S176.
Web of Science

 

Enzinger, C; Ropele, S; Strasser-Fuchs, S; Matthews, P; Kapeller, R; Smith, S; Fazekas, F A combined longitudinal MRI analysis assessing spectroscopic, brain volume and focal brain tissue changes suggests a limited effect of immunomodulatory agents on the progression of relapsing-remitting multiple sclerosis
MULT SCLER 2004 10: S223-S223. [Poster]
Web of Science

 

Enzinger C, Strasser-Fuchs S, Ropele S, Kapeller P, Kleinert R, Fazekas F. Der Beitrag von konventioneller Kernspintomographie, Protonenspektroskopie und Magnetisierungstransfer Imaging zur Diagnose von atypischen Fällen mit tumorösen Marklagerläsionen demyelinisierender Ätiologie.
2. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); April, 2004; Linz. 2004. [Poster]

 

Enzinger C, Ropele S, Smith S, Strasser-Fuchs S, Poltrum B, Schmidt H, Matthews P, Fazekas F. Tissue damage in multiple sclerosis and the APOE genotype – MRI analysis of brain volume changes and the evolution of “black holes” during two years of follow-up.
Multiple Sclerosis. 2003; 9(S1):S13--19th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; September 17¿20; Milan, Italy. [Poster]

 

Enzinger C, Ropele S, Strasser–Fuchs S, Kapeller P, Schmidt H, Poltrum B, Schmidt R, Hartung H.-P, Fazekas F Protonenspektroskopische Verlaufsuntersuchung zeigt stärkere Reduktion von N-Acetylaspartat bei Multiple Sklerose Betroffenen mit dem Apolipoprotein E e4 Allel.
1. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); Innsbruck. 2003. [Oral Communication]

 

Enzinger C, Strasser-Fuchs S, Ropele S, Kapeller P, Kleinert R, Fazekas F. Contribution of conventional MRI, MR spectroscopy and magnetization transfer imaging to the diagnosis of demyelination with a tumour-like appearance.
Multiple Sclerosis. 2003; 9(S1):S65--19th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.; September 17¿20; Milan, Italy. [Poster]

 

Poltrum B, Enzinger C, Strasser–Fuchs S, Ropele S, Kapeller P, Schmidt H, Schmidt R, Fazekas F tärkere Zunahme an T1-hypointensen Läsionen („black holes“) als Hinweis für höhere Gewebsdestruktion in Gehirnen Multiple Sklerose Betroffener mit dem APOEe4 Allel
1. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); Innsbruck. 2003. [Poster]

 

Ropele S, Enzinger C, Strasser-Fuchs S, Fazekas F Comparison of the myelin related proton pool and the MTR in multiple sclerosis lesions
Multiple Sclerosis 2003;9(S1):S20. 2003; -ECTRIMS; September 17–20; Milan, Italy. [Keynote lecture]

 

Enzinger C, Kapeller P, Strasser-Fuchs S, Ropele S, Schmidt H, Poltrum B, Schmidt R, Fazekas F. Protonenspektrokopische Verlaufsuntersuchung zeigt stärkere N-Acetlyaspartat Reduktion bei Multiple Sklerose Betroffenen mit dem APOE e4Allel
Gemeinsame Tagung der Österreichischen Gesellschaft für Neurologie (ÖGN) und der Österreichischen Gesellschaft für Psychiatrie (ÖGP); Gmunden. 2002. [Oral Communication]

 

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Poltrum B, Schmidt H, Schmidt R, Fazekas F Serielle Kernspintomographische Veränderungen bei Multipler Sklerose in Abhängigkeit vom Apolipoprotein E Genotyp.
Gemeinsame Tagung der Österreichischen Gesellschaft für Neurologie (ÖGN) und der Österreichischen Gesellschaft für Psychiatrie (ÖGP); Gmunden. 2002. [Oral Communication]

 

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Poltrum B, Schmidt H, Schmidt R, Fazekas F. Higher proportion of black holes in MS patients with APOE e4 allele.
Journal of Neurology. 2002; 249(S1):174--Twelfth Meeting of the European Neurological Society (ENS); June 22¿26; Berlin, Germany. [Poster]

 

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Seifert T, Poltrum B, Schmidt H, Schmidt R, Fazekas F Evidence of more extensive tissue damage in MS patients with APOE-e4: two-year MRI follow-up shows higher proportion of lesions evolving to “black holes”.
European Journal of Neurology. 2002; 9(S2):29--6. Sixth European Federation Neurologic Society (EFNS) Congress; 26 - 30 October ; Vienna. [Oral Communication]

 

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Seifert T, Poltrum B, Schmidt H, Schmidt R, Fazekas. F MRI evidence of more extensive tissue damage in MS patients with the e4 allele of Apolipoprotein E: higher proportion of lesions evolving to “black holes” during two-year follow-up.
Multiple Sclerosis 2002;(S1):3.2002; -7th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis and 18th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; September 18-21; Baltimore, Maryland, USA.. [Oral Communication]

 

Neuhaus, O; Strasser-Fuchs, S; Fazekas, F; Hartung, HP; Archelos, JJ Multiple sclerosis: Immunologic effects of statins in vitro: A new therapeutic approach?
NEUROLOGY 2002 58: A73-A73.
Web of Science

 

Ropele S, Strasser-Fuchs S, Enzinger C, Seifert T, Fazekas F Quantitative Analyse des Magnetisierungstransfers im normal erscheinenden Marklager bei Multipler Sklerose.
Gemeinsame Tagung der Österreichischen Gesellschaft für Neurologie (ÖGN) und der Österreichischen Gesellschaft für Psychiatrie (ÖGP); Gmunden. 2002. [Oral Communication]

 

Ropele S, Strasser-Fuchs S, Seifert T, Enzinger C, Fazekas F. Development of active multiple sclerosis lesions: a quantitative MT study.
Proc. of the International Society for Magnetic Resonance in Medicine. 2002; -International Society for Magnetic Resonance in Medicine, 10th scientific meeting; Nov; Honolulu. [Oral Communication]

 

Enzinger C, Ropele S, Strasser-Fuchs S, Schmidt H, Kapeller P, Poltrum B, Schmidt R, Hartung H.P, Fazekas F. Apolipoprotein E e4 is associated with lower concentrations of N-acetylaspartate (NAA): a longitudinal 1H-MRS study in MS.
Multiple Sclerosis 2001;7(S1):288.2001; -ECTRIMS; Sept; Dublin. [Poster]

 

Ropele S, Strasser-Fuchs S, Seifert T, Enzinger C, Kapeller P, Fazekas F. Development of active multiple sclerosis lesions: a quantitative magnetization transfer study
Multiple Sclerosis 2001;7 (S1):S912001; -17th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; 12-15 September; Dublin, Ireland. [Oral Communication]

 

Seifert, T; Kieseier, BC; Ropele, S; Strasser-Fuchs, S; Fazekas, F; Hartung, HP Tumor necrosis factor-alpha-converting enzyme mRNA expression in peripheral mononuclear cells precedes lesion appearance on MRI in relapsing-remitting multiple sclerosis
NEUROLOGY 2001 56: A294-A294.
Web of Science

 

Bammer, R; Augustin, M; Seifert, T; Strasser-Fuchs, S; Stollberger, R; Wach, P; Hartung, HP; Fazekas, F High resolution diffusion tensor imaging using interleaved echo-planar imaging
In: Chen, CT; Clough, AV editor(s).PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS (SPIE); MEDICAL IMAGING 2000: PHYSIOLOGY AND FUNCTION FORM MULTIDIMENSIONAL IMAGES; FEB 13-17, 2000; SAN DIEGO, CALIFORNIA. BELLINGHAM: SPIE - INT SOC

 

Bammer, R; Stollberger, R; Augustin, M; Seifert, T; Strasser-Fuchs, S; Wach, P; Hartung, HP; Fazekas, F Parallel imaging strategies for high-speed Magnetic Resonance diffusion imaging
In: Chen, CT; Clough, AV editor(s).PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS (SPIE); MEDICAL IMAGING 2000: PHYSIOLOGY AND FUNCTION FORM MULTIDIMENSIONAL IMAGES; FEB 13-17, 2000; SAN DIEGO, CALIFORNIA. BELLINGHAM: SPIE - INT SOC

 

Ropele, S; Strasser-Fuchs, S; Augustin, M; Stollberger, R; Enzinger, C; Toyka, K; Hartung, HP; Fazekas, F Quantitative Magnetization Transfer Imaging in Patients with Multiple Sclerosis.
Proc. of the International Society for Magnetic Resonance in Medicine2000; -8th scientific meeting International Society for Magnetic Resonance in Medicine; Nov; Denver. [Oral Communication]

 

Ropele S, Strasser-Fuchs S, Augustin M, Stollberger R, Enzinger C, Toyka K, Hartung H-P, Fazekas F. Quantitative magnetization transfer imaging in relapsing multiple sclerosis
Proceedings of the International Society of Magnetic Resonance in Medicine 2000;8:1185.2000; -8th Meeting of the International Society of Magnetic Resonance in Medicine; 1-7 April; Denver, CO, USA. [Poster]

 

Fazekas F, Enzinger C, Strasser-Fuchs S, Schmidt H, Lechner A, Ropele S, Flooh E, Schmidt R, Hartung HP. ApoE genotype of MS patients affects the severity of tissue destruction as seen on MRI.
Journal of Neurology 1999;246(S1), I/35. 1999; -Twelfth Meeting of the European Neurological Society; 22–26 June; Berlin, Germany. [Oral Communication]

 

Strasser-Fuchs S, Schmidt H, Fazekas F, Enzinger C, Lechner A, Flooh E, Schmidt R, Hartung H-P ApoE genotype and clinical course of MS: a cross-sectional study.
Journal of Neurology 1999;246(S1),I/601999; -Twelfth Meeting of the European Neurological Society; 22–26 June; Berlin, Germany. [Poster]

 

Strasser-Fuchs, S; Offenbacher, H Therapie der Multiplen Sklerose
Fortbildungsveranstaltung der Universitätsklinik für Neurologie; DEC 20, 1995; Graz, AUSTRIA. 1995. [Oral Communication]

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum